Addressing the HIV/AIDS epidemic among puerto rican people who inject drugs: The need for a multiregion approach

American Journal of Public Health

Volumn 104, Issue 11, 2014, Pages 2030-2036

  Deren, Sherry ^a   Gelpí Acosta, Camila ^b   Albizu García, Carmen E ^c   González, Ángel ^d   Des Jarlais, Don C ^e   Santiago Negrón, Salvador ^d  

^a NEW YORK UNIVERSITY   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^d Admin Servicios de Salud Mental Contra la Adiccion   (Puerto Rico)

^e BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLICATION; DRUG DEPENDENCE TREATMENT; EPIDEMIOLOGY; ETHNOLOGY; HEALTH DISPARITY; HISPANIC; HIV INFECTIONS; HUMAN; INCIDENCE; PREVENTIVE HEALTH SERVICE; PUERTO RICO; RISK FACTOR; SUBSTANCE ABUSE; UNITED STATES;

HEALTH STATUS DISPARITIES; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; INCIDENCE; NEEDLE-EXCHANGE PROGRAMS; NEW ENGLAND; NEW YORK CITY; PUERTO RICO; RISK FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84907842274     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.302114     Document Type: Review

References (75)

1. US Census Bureau. American Community Survey 1-year estimates. 2012. Available at: http://factfinder2.census.gov. Accessed December 5, 2013.
2. Centers for Disease Control and Prevention. HIV/AIDS epidemic and HIV/AIDS prevention in the Hispanic/Latino community: consultation with leaders from the Latino community. 2008. Available at: http://www.cdcnpin.org/scripts/HispanicLatino/files/SummaryReport-0509.pdf. Accessed November 26, 2013.
3. Diaz T, Buehler JW, Castro KG, Ward JW. AIDS trends among Hispanics in the United States. Am J Public Health. 1993;83(4):504-509.
4. Centers for Disease Control and Prevention. Geographic differences in HIV infection among Hispanics or Latinos-46 states and Puerto Rico, 2010. MMWR Morb Mortal Wkly Rep. 2012; 61(40):805-810.
5. Centers for Disease Control and Prevention. HIV/AIDS among Hispanics-United States, 2001-2005. MMWR Morb Mortal Wkly Rep. 2007;56(40):1052-1057.
6. Cohen MS, Holmes C, Padian N, et al. HIV treatment as prevention: how scientific discovery occurred and translated rapidly into policy for the global response. Health Aff (Millwood). 2012;31(7):1439-1449.
7. Bakeman R, Lumb JR, Smith DW. AIDS statistics and the risk for minorities. AIDS Res. 1986;2(3):249-252.
8. Friedman SR, Sotheran JL, Abdul-Quader A, et al. The AIDS epidemic among Blacks and Hispanics. Milbank Q. 1987;65(suppl 2):455-499.
9. Robles RR, Colon HM, Matos TD, Reyes JC, Marrero CA, Lopez CM. Risk factors and HIV infection among three different cultural groups of injection drug users. In: Brown BS, Beschner GM, eds. Handbook on Risk of AIDS: Injection Drug Users and Sexual Partners. Westport, CT: Greenwood Press; 1993:256-274.
10. López LM, Zerden LD, Fitzgerald TC, Lundgren LM. Puerto Rican injection drug users: prevention implications in Massachusetts and Puerto Rico. Eval Program Plann. 2008;31(1):64-73.
11. Deren S, Kang SY, Colón HM, Andia JF, Robles RR. HIV incidence among high-risk Puerto Rican drug users: a comparison of East Harlem, New York, and Bayamón, Puerto Rico. J Acquir Immune Defic Syndr. 2004;36(5):1067-1074.
12. Singer M, Jia Z. AIDS and Puerto Rican injection drug users in the United States. In: Brown BS, Beschner GM, eds. Handbook on Risk of AIDS: Injection Drug Users and Sexual Practices. Westport, CT: Greenwood Press; 1993:227-255.
13. Pouget ER, Friedman SR, Cleland CM, Tempalski B, Cooper HL. Estimates of the population prevalence of injection drug users among Hispanic residents of large US metropolitan areas. J Urban Health. 2012;89(3):527-564.
14. Mino M, Deren S, Colón HM. HIV and drug use in Puerto Rico: findings from the ARIBBA study. J Int Assoc Physicians AIDS Care. 2011;10(4):248-259.
15. Colón HM, Robles RR, Deren S, et al. Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamon, Puerto Rico. J Acquir Immune Defic Syndr. 2001;27(4):405-413.
16. Deren S, Oliver-Velez D, Finlinson A, et al. Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Subst Use Misuse. 2003;38(1):1-24.
17. Zerden LD, Marilis Lopez L, Lundgren LM. Needle sharing among Puerto Rican injection drug users in Puerto Rico and Massachusetts: place of birth and residence matter. Subst Use Misuse. 2010;45(10):1605-1622.
18. Robles RR, Matos TD, Colón HM, et al. Determinants of health care use among Puerto Rican drug users in Puerto Rico and New York City. Clin Infect Dis. 2003;37(suppl 5):S392-S403.
19. Colón HM, Deren S, Robles RR, Kang SY, Cabassa M, Sahai H. A comparative study of mortality among Puerto Rican injection drug users in East Harlem, New York, and Bayamon, Puerto Rico. J Urban Health. 2006;83(6):1114-1126.
20. Finlinson HA, Oliver-Vélez D, Colón HM, et al. Syringe acquisition and use of syringe exchange programs by Puerto Rican drug injectors in New York and Puerto Rico: comparisons based on quantitative and qualitative methods. AIDS Behav. 2000;4(4):341-351.
21. Zerden LD, López LM, Lundgren L. HIV prevention interventions with Puerto Rican injection drug users. In: Organista K, ed. HIV Prevention With Latinos: Theory, Research, and Practice. New York, NY: Oxford University Press; 2012:383-405.
22. Deren S, Kang SY, Colón HM, et al. Migration and HIV risk behaviors: Puerto Rican drug injectors in New York City and Puerto Rico. Am J Public Health. 2003;93(5):812-816.
23. Centers for Disease Control and Prevention. HIV surveillance report. Vol. 23. 2011. Available at: http://www.cdc.gov/hiv/library/reports/surveillance/2011/surveillance-Report-vol-23.html. Accessed November 26, 2013.
24. Puerto Rico Department of Health, HIV/AIDS Surveillance Program. Cumulative HIV/AIDS cases diagnosed as of October 31, 2013. Available at: http://www.salud.gov.pr/Programas/OficEpidemiologia/Estadisticas%20Generales/Puerto%20Rico%20HIVAIDS%20Surveillance%20Summary%20octubre%202013.pdf. Accessed November 27, 2013.
25. Perfil Epidemiológico Integrado para la Prevención del VIH en Puerto Rico, 2005-2011 [Integrated epidemiological profile for HIV prevention in Puerto Rico, 2005-2011]. San Juan, PR: Department of Health of Puerto Rico; 2012.
26. Friedman SR, West BS, Tempalski B, et al. Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals? Ann Epidemiol. 2014;24(4):304-311.
27. Centers for Disease Control and Prevention. HIV and AIDS in the United States by geographic distribution. 2013. Available at: http://www.cdc.gov/hiv/statistics/basics/geographicdistribution.html. Accessed November 26, 2013.
28. Brown A, Lopez MH. Mapping the Latino population, by state, county and city. Pew Research Hispanic Trends Project. 2013. Available at: http://www.pewhispanic.org/2013/08/29/mapping-the-latino-population-by-state-county-and-city. Accessed December 15, 2013.
29. Des Jarlais DC, Arasteh K, Friedman SR. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Subst Use Misuse. 2011;46(2-3):131-139.
30. HIV Epidemiology and Field Services Surveillance Statistics. Vol 8, No 1. New York, NY: New York City Department of Health and Mental Hygiene; 2013.
31. Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95(8):1439-1444.
32. Neaigus A, Reilly KH, Jenness SM, Hagan H, Wendel T, Gelpi-Acosta C. Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City. AIDS Behav. 2013;17(7):2501-2509.
33. Gelpí-Acosta C, Hagan H, Jenness SM, Wendel T, Neaigus A. Sexual and injection-related risks in Puerto Ricanborn injection drug users living in New York City: a mixed-methods analysis. Harm Reduct J. 2011;8:28.
34. HIV/AIDS Among Latinos in New Jersey. Trenton: New Jersey Department of Health and Senior Services; 2010. Available at: http://www.state.nj.us/health/aids/documents/latino-hiv-factsheet.pdf. Accessed January 11, 2014.
35. Connecticut Department of Public Health. Total HIV Infection cases by sex, race, and risk (1981-2012). 2013. Available at: http://www.ct.gov/dph/lib/dph/aids-and-chronic/surveillance/statewide/ct-total-hivaids-table.pdf. Accessed December 10, 2013.
36. Massachusetts Executive Office of Health and Human Services, Department of Public Health, Office of HIV/AIDS. Massachusetts HIV/AIDS data fact sheet: the Massachusetts HIV/AIDS epidemic at a glance. 2012. Available at: http://www.mass.gov/eohhs/docs/dph/aids/2012-profiles/epidemic-glance.pdf. Accessed January 11, 2014.
37. Philadelphia Department of Public Health, AIDS Activities Coordinating Office. AIDS Activities Coordinating Office Surveillance Report, 2012: HIV/AIDS in Philadelphia. Philadelphia, PA: City of Philadelphia Department of Health; 2013.
38. MacArthur GJ, van Velzen E, Palmateer N, et al. Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34-52.
39. Aspinall EJ, Nambiar D, Goldberg DJ, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235-248.
40. MacArthur GJ, Minozzi S, Martin N, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012;345:e5945.
41. Des Jarlais DC, Pinkerton S, Hagan H, et al. 30 years on selected issues in the prevention of HIV among persons who inject drugs. Adv Prev Med. 2013;2013:346372.
42. Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction. 2009;104 (9):1441-1446.
43. Office of National Drug Control Policy. National Drug Control Strategy. Washington, DC: White House; 2013. Available at: http://www.whitehouse.gov/sites/default/files/ndcs-2013.pdf. Accessed December 3, 2013.
44. Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000;59(1):17-31.
45. Sullivan LE, Metzger DS, Fudala PJ, Fiellin DA. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction. 2005;100(2):150-158.
46. Bruce RD. Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings. Int J Drug Policy. 2010;21(2):122-124.
47. Hansen H. Faith-based treatment for addiction in Puerto Rico. JAMA. 2004;291(23):2882.
48. Hansen H. Isla evangelista - a story of church and state: Puerto Rico's faith-based initiatives in drug treatment. Cult Med Psychiatry . 2005;29(4):433-456.
49. Mental Health Code of Puerto Rico. Act No. 183. Para enmendar la Ley Núm. 408 de 2000: Ley de Salud Mental de Puerto Rico [To amend Act No. 408 of 2000: Mental Health Act of Puerto Rico]; 2008. Available at: http://www.lexjuris.com/lexlex/leyes2008/lexl2008183.htm. Accessed November 25, 2013.
50. Office of Applied Studies. The TEDS Report: Puerto Rican Admissions to Substance Abuse Treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2010.
51. Torruella RA. ¿Allá en Nueva York Todo es Mejor? [Everything is Better Back in New York?]: A Qualitative Study on the Relocation of Drug Users From Puerto Rico to the United States [dissertation]. New York, NY: City University of New York; 2010.
52. Restrepo E. Via de los zombis [Zombie rail]. Al Dia. November 6, 2013. Available at: http://aldianews.com/articles/local/philadelphia/de-loszombis/32613. Accessed November 11, 2013.
53. Ryan White Part B Program. Puerto Rico Statewide Coordinated Statement of Need 2012 and HIV Treatment Comprehensive Plan 2012-2015 . San Juan, PR: Puerto Rico Department of Health; 2012. Available at: http://www.salud.gov.pr/Programas/ryanwhiteparteb/Pages/publicacionesdeinteres.aspx. Accessed December 3, 2013.
54. Ryan White Part B Program. Personas con VIH no duplicadas, recibiendo servicios en los CPTETs por género, modo de exposición, categoría de servicios recibidos y CPTET (Enero 2012 hasta Diciembre 2012) [Unduplicated Number of People living with HIV receiving services through CPTET by gender, exposure, service category and CPTET (January 2012 to December 2012)]. San Juan, PR: Puerto Rico Department of Health; 2013.
55. Eckholm E. Puerto Rico's AIDS care in disarray over funds. New York Times. June 5, 2007:A1.
56. AIDS Institute. Ryan White 2012 Statewide Coordinated Statement of Need and Comprehensive Plan. Albany, NY: New York State Department of Health; 2012.
57. New Jersey Department of Health and Senior Services, Division of HIV, STD, and TB Services. New Jersey Statewide Coordinated Statement of Need, 2012. New Brunswick, NJ: Edward J. Bloustein School of Planning and Public Policy, Rutgers University; 2013.
58. Pfeiffer MR, Hanna DB, Begier EM, Sepkowitz KA, Zimmerman R, Sackoff JE. Excess mortality among injection drug users with AIDS, New York City (1999-2004). Subst Use Misuse. 2011;46(2-3):245-253.
59. Lelutiu-Weinberger C, Pouget ER, Des Jarlais DC, et al. A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Soc Sci Med. 2009;68(3):579-590.
60. US Department of Justice. Puerto Rico/US Virgin Islands High Intensity Drug Trafficking Area: Drug Market Analysis 2011. Johnstown, PA: National Drug Intelligence Center; 2011.
61. Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med. 2005;353(18):1945-1954.
62. Reyes JC, Negron JL, Colón HM, et al. The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico. J Urban Health. 2012;89(3):519-526.
63. Torruella RA. Xylazine (veterinary sedative) use in Puerto Rico. Subst Abuse Treat Prev Policy. 2011;6:7.
64. Rodríguez N, Vargas Vidot J, Panelli J, Colón H, Ritchie B, Yamamura Y. GCMS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles. Drug Alcohol Depend. 2008;96(3):290-293.
65. Wong SC, Curtis JA, Wingert WE. Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office. J Forensic Sci. 2008;53(2):495-498.
66. Espinoza L, Hall HI, Hu X. Diagnoses of HIV infection among Hispanics/Latinos in 40 states and Puerto Rico, 2006-2009. J Acquir Immune Defic Syndr. 2012;60(2):205-213.
67. Chen NE, Gallant JE, Page KR. A systematic review of HIV/AIDS survival and delayed diagnosis among Hispanics in the United States. J Immigr Minor Health. 2012;14(1):65-81.
68. Kaiser Family Foundation, Kaiser Health News. CDC report on new HIV infections in U.S. did not include data from Puerto Rico; omission has widespread consequences, advocates say. 2008. Available at: http://www.kaiserhealthnews.org/daily-reports/2008/september/02/dr00054226. Accessed November 25, 2013.
69. Insurance Code of Puerto Rico. Act No. 140. Para requerir a toda aseguradora, organización de servicios de salud organizada conforme a la Ley Núm. 77 de 1957: Código de Seguros de Puerto Rico [To require all insurance, organization of health services organized under Act No. 77 of 1957: Insurance Code of Puerto Rico], 2010. Available at: http://www.lexjuris.com/lexlex/leyes2010/lexl2010140.htm. Accessed November 25, 2013.
70. Consensus Statement of the Reference Group to the United Nations on HIV and Injecting Drug Use, 2010 . Sydney, Australia: University of New South Wales; 2010.
71. Heimer R, Zambrano JA, Brunet A, Ortiz AM, Catania H, Newman RG. Methadone maintenance in a men's prison in Puerto Rico: a pilot program. J Correct Health Care. 2005;11(3):295-305.
72. Garcia CA, Correa GC, Viver AD, et al. Buprenorphine-naloxone Treatment for Pre-release Opioid-dependent Inmates in Puerto Rico. J Addict Med. 2007;1(3):126-132.
73. Guerrero EG, Marsh JC, Khachikian T, Amaro H, Vega WA. Disparities in Latino substance use, service use, and treatment: implications for culturally and evidence-based interventions under health care reform. Drug Alcohol Depend. 2013;133(3):805-813.
74. Ismailidou E, Trianni F. The next financial catastrophe you haven't heard about yet: Puerto Rico. Time. March 12, 2014. Available at: http://time.com/20416/the-next-financial-catastrophe-you-havent-heard-about-yet-puerto-rico. Accessed May 2, 2014.
75. Guzman TA. US hegemony and Puerto Rico's economic crisis. Global Research. December 17, 2013. Available at: http://www.globalresearch.ca/us-hegemony-and-puerto-ricos-economiccrisis/5361819. Accessed April 30, 2014.